The eRapid Nebulizer for the Delivery of Inhaled Therapies for CF Information for CF Centers
نویسنده
چکیده
Orally inhaled therapies are a cornerstone of lung health maintenance in CF. Topical application of drugs in the airways increases the efficacy and reduces the systemic exposure and toxicity of these agents. Most CF patients are treated with aerosolized therapies, and many take multiple inhaled drugs on a daily basis. Treatments for bronchodilation, inflammation, airway clearance and early or chronic infection create a significant time burden for patients, leading to nonadherence with therapies and poorer outcomes. Newer aerosol delivery systems have been developed to improve one or more of the perceived deficiencies of standard aerosol devices, including convenience, portability, and time burden.
منابع مشابه
Maintaining Respiratory Health in Cystic Fibrosis Patients
Cystic fibrosis (CF) is an inherited disease that primarily affects the lungs and the digestive system, however, it also affects a number of other organs and systems. More than 90% of mortality of CF patients is due to lung complications. Healthy lungs are important for a long life for people with CF, We will discuss two important topics for maintaining respiratory health. Chronic use of drug...
متن کاملInhaled therapy in cystic fibrosis: agents, devices and regimens
KEY POINTS There have been significant advances in both inhalation medicines and delivery devices with "intelligent nebulisers" and "dry-powder inhalers" becoming commonplace in CF care.Inhaled medicines generate high levels of a drug within the airways with limited systemic effects, offering safe and convenient antibiotic and mucolytic therapy for individuals with CF.Variations in adherence ar...
متن کاملHypertonic saline and PEP: is it worth a try?
Cystic fibrosis (CF) is a recessive genetic disease that requires aggressive therapies to slow the disease progression. CF is a complex disorder that primarily affects the digestive system and the lungs. A major characteristic of CF is lung disease, which is responsible for the majority of CF-related deaths. CF is caused by an absent or deficient CF transmembrane regulator, which is a protein r...
متن کاملAerosol antibiotics in cystic fibrosis.
Chronic airways infection and inflammation is the greatest source of morbidity and mortality in cystic fibrosis (CF) patients. Many organisms can be found in the lower respiratory tract of CF patients, but infection with mucoid Pseudomonas aeruginosa is common, is associated with poorer outcomes, and is the main target for antimicrobial strategies in CF. Aerosol antibiotics achieve high local c...
متن کاملNew aerosol delivery devices for cystic fibrosis.
Cystic fibrosis (CF) patients use several therapies to treat chronic inflammation and infection in the lungs and to improve airway clearance. Inhaled therapies in CF typically include bronchodilators, airway wetting agents, mucus-active agents, and antibiotics, among others. There are many variables to take into account when prescribing aerosolized therapies to CF patients, including aerosol fa...
متن کامل